- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IX Biopharma Ltd (IXBI)
IX Biopharma Ltd stock price live, this page displays SGX IXBI stock exchange data. View the IXBI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IX Biopharma Ltd real time stock price chart below.
What Is the IX Biopharma Ltd Stock Price Today?
The IX Biopharma Ltd stock price today is 0.430.
What Is the Stock Symbol for IX Biopharma Ltd?
The stock symbol for IX Biopharma Ltd is "IXBI."
What Stock Exchange Does IX Biopharma Ltd Trade On?
IX Biopharma Ltd is listed and trades on the Singapore stock exchange.
Is IX Biopharma Ltd a Good Stock to Buy?
Determining whether IX Biopharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IXBI quote. (ISIN: SG1BD9000009)
What Is the IX Biopharma Ltd Stock Price Today?
The IX Biopharma Ltd stock price today is 0.430.
What Is the Stock Symbol for IX Biopharma Ltd?
The stock symbol for IX Biopharma Ltd is "IXBI."
What Stock Exchange Does IX Biopharma Ltd Trade On?
IX Biopharma Ltd is listed and trades on the Singapore stock exchange.
Is IX Biopharma Ltd a Good Stock to Buy?
Determining whether IX Biopharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IXBI quote. (ISIN: SG1BD9000009)
Singapore
Currency in SGD
0.430
+0.005(+1.18%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.420
0.435
52 wk Range
0.018
0.585
IXBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4200.435
52 wk Range
0.0180.585
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IXBI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High return over the last year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
Aug 21, 2026
EPS / Forecast
-- / --
Revenue / Forecast
2.09M / --
Compare IXBI to Peers and Sector
Metrics to compare | IXBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIXBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −57.2x | −1.6x | −0.4x | |
PEG Ratio | −2.04 | −0.02 | 0.00 | |
Price/Book | 29.7x | 1.8x | 2.6x | |
Price / LTM Sales | 66.8x | 2.5x | 3.1x | |
Upside (Analyst Target) | - | 97.7% | 49.4% | |
Fair Value Upside | Unlock | 2.5% | 6.8% | Unlock |
iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, Australia and internationally. The company operates through Specialty Pharmaceutical and Nutraceutical segments. It offers Wafesil and Silcap for the treatment of male erectile dysfunction; as well as Hypera, a sublingual tetrahydrocannabinol wafer for chronic pain, anxiety, insomnia and other conditions. The company is also developing Wafermine, a racemic ketamine sublingual wafer, which has completed phase-2 clinical trial for the treatment of complex regional pain syndrome, as well as psychiatric conditions, including depression; iXB 401, a sublingual semaglutide wafer that is in pre-clinical development for the treatment of Type 2 Diabetes and Obesity; SL-NAD+, a sublingual NAD+ wafer to increase the body’s NAD+ levels, energy levels, and alertness. In addition, it develops BnoX that is in a phase-1 clinical trial for moderate to severe pain; NAD+ for sarcopenia; and LumeniX, a sublingual glutathione wafer for skin brightening and immunity. iX Biopharma Ltd. was incorporated in 2004 and is headquartered in Singapore.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the IX Biopharma Ltd (IXBI) Stock Price Today?
The IX Biopharma Ltd stock price today is 0.430 SGD.
What Stock Exchange Does IX Biopharma Ltd Trade On?
IX Biopharma Ltd is listed and trades on the Singapore Stock Exchange.
What Is the Stock Symbol for IX Biopharma Ltd?
The stock symbol for IX Biopharma Ltd is "IXBI."
What Is the IX Biopharma Ltd Market Cap?
As of today, IX Biopharma Ltd market cap is 468.350M SGD.
What Is IX Biopharma Ltd's Earnings Per Share (TTM)?
The IX Biopharma Ltd EPS (TTM) is -0.008.
From a Technical Analysis Perspective, Is IXBI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has IX Biopharma Ltd Stock Split?
IX Biopharma Ltd has split 2 times.
How Many Employees Does IX Biopharma Ltd Have?
IX Biopharma Ltd has 35 employees.
What is the current trading status of IX Biopharma Ltd (IXBI)?
As of Sep 01, 2026, IX Biopharma Ltd (IXBI) is trading at a price of 0.430 SGD, with a previous close of 0.425 SGD. The stock has fluctuated within a day range of 0.420 SGD to 0.435 SGD, while its 52-week range spans from 0.018 SGD to 0.585 SGD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.